Headache, Migraine Clinical Trial
Official title:
To Investigate the Headache Induction and the Cerebral Hemodynamic Changes After Infusion of Adenosine in Healthy Volunteers and Migraine Patient
Verified date | November 2022 |
Source | Danish Headache Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Adenosine is a nucleoside that plays a role in both vascular and nociceptive systems, and it has been proposed that adenosine may cause headache in particularly sensitive subjects. Thus, considerable evidence implied that adenosine plays a role in migraine pathophysiology, it is still unknown if intravenous adenosine infusion provokes migraine attacks in healthy subject or in migraine patients. Furthermore, adenosine's effects on the cerebral hemodynamic remains unknown. This study aims to clarify a possible coherence between adenosine and headache/migraine. In general, the study will contribute to a greater understanding of migraine pathogenesis and possibly lead to development of specific migraine treatment.
Status | Completed |
Enrollment | 18 |
Est. completion date | October 30, 2021 |
Est. primary completion date | October 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Migraine patients without aura who fulfill criteria in the international classification of headaches. This does not apply to healthy volunteers. - 18-60 years. - 50-90 kg. - Women of childbearing potential must use adequate contraception Exclusion Criteria: - Headache less than 48 hours before the tests start - All primary headaches, except migraine without aura for migraine patients, according to international classification of headache - Daily consumption of drugs of any kind other than oral contraceptives - Pregnant or nursing women. - Cardiovascular disease of any kind, including cerebrovascular diseases. |
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet-Glostrup | Glostrup | Nordre Ringvej 57 |
Lead Sponsor | Collaborator |
---|---|
Danish Headache Center |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Occurrence and change of migraine attack | Occurrence and of migraine according to international criteria | Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline | |
Secondary | Change in cerebral hemodynamic | Change on velocity of media cerebri artery. | Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline | |
Secondary | Occurrence and change of headache | Occurrence of headache measured by numerical rating scale (NRS) | Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline | |
Secondary | Change of diameter of the artery | Change of diameter of superficial temporal artery and radial artery. The diameter will be measured by millimeter (mm). | Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05503082 -
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
|
Phase 4 | |
Completed |
NCT04905654 -
Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura
|
N/A | |
Completed |
NCT04111484 -
Adrenomedullin Effect on Migraine Without Patients
|
N/A | |
Recruiting |
NCT04091789 -
Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
|
Phase 2 | |
Completed |
NCT03337620 -
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
|
Phase 3 | |
Completed |
NCT02259387 -
Adolescents With Migraine: What's Stress Got To Do With It?
|
||
Completed |
NCT05658185 -
Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient
|
N/A | |
Completed |
NCT05001399 -
Feasibility of Using Holographic Memory Resolution® (HMR) in Patients/Clients With Pain
|
N/A | |
Completed |
NCT03490500 -
Using the S100B Protein for Emergency Headache Management Care (S100)
|
||
Completed |
NCT03075020 -
Carbon Monoxide Migraine-inducing Effects in Patients With Migraine Without Aura.
|
N/A | |
Recruiting |
NCT03472092 -
Mind and Body Approaches to Pain Reduction in Youth With Migraine
|
Phase 2 | |
Enrolling by invitation |
NCT04976985 -
Osteopathic Manipulative Treatment and Migraine Headaches
|
N/A | |
Active, not recruiting |
NCT04372264 -
Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache
|
Phase 4 | |
Recruiting |
NCT04623203 -
The Prognosis of Migraine and Tension-Type Headache in Children and Adolescents
|
||
Completed |
NCT03560024 -
The Effect of PACAP27 on the Extra- and Intracerebral Arteries Assessed by Magnetic Resonance Angiography (MRA) on Healthy Volunteers
|
N/A | |
Completed |
NCT03228355 -
Headache Inducing Effect of Cromakalim in Migraine Patients
|
N/A | |
Completed |
NCT02438553 -
Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain
|
N/A | |
Recruiting |
NCT03577548 -
Influence of Main Psychological and Social Factors on Primary Headaches
|
||
Recruiting |
NCT04715685 -
Mind Body Balance for Pediatric Migraine
|
N/A | |
Completed |
NCT05853900 -
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
|
Phase 3 |